UHS Insider Trading
UNIVERSAL HEALTH SERVICES INC | Services-General Medical & Surgical Hospitals, NEC
Comprehensive Trading Performance Summary
The investment history of corporate insiders at UNIVERSAL HEALTH SERVICES INC provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-General Medical & Surgical Hospitals, NEC sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-12 16:24 | 2025-11-11 | Nimetz Warren J. | Director | OPT+S | $223.30 | 3,817 | $852,343 | 8,481 | 0.0% |
| 2025-10-30 23:23 | 2025-10-29 | SUSSMAN ELLIOT J MD MBA | Director | OPT+S | $225.70 | 965 | $217,799 | 6,113 | 0.0% |
| 2025-05-15 23:29 | 2025-05-14 | Singer Maria Ruderman | Director | SELL | $191.48 | 1,097 | $210,053 | 7,884 | -12.2% |
| 2025-03-11 23:07 | 2025-03-10 | Singer Maria Ruderman | Director | OPT+S | $179.16 | 1,000 | $179,161 | 7,916 | 0.0% |
| 2024-12-13 00:03 | 2024-12-11 | Singer Maria Ruderman | Director | OPT+S | $191.15 | 1,614 | $308,516 | 5,879 | 0.0% |
| 2024-08-15 16:12 | 2024-08-13 | SUSSMAN ELLIOT J MD MBA | Director | OPT+S | $218.08 | 1,722 | $375,534 | 5,048 | 0.0% |
| 2024-08-14 16:22 | 2024-08-12 | Nimetz Warren J. | Director | OPT+S | $217.64 | 3,444 | $749,552 | 3,971 | 0.0% |
| 2024-08-08 23:04 | 2024-08-07 | Chen-Langenmayr Nina | Director | SELL | $212.11 | 850 | $180,294 | 1,985 | -30.0% |
| 2024-07-29 23:15 | 2024-07-26 | McDonnell Eileen C. | Director | OPT+S | $209.55 | 2,535 | $531,211 | 6,413 | 0.0% |
| 2024-07-29 23:12 | 2024-07-26 | SUSSMAN ELLIOT J MD MBA | Director | OPT+S | $210.00 | 2,541 | $533,616 | 5,048 | 0.0% |
| 2024-07-29 23:08 | 2024-07-26 | Peterson Matthew Jay | Officer - Executive Vice President, UHS | OPT+S | $210.85 | 15,141 | $3,192,459 | 5,253 | 0.0% |
| 2024-05-16 23:12 | 2024-05-16 | Nimetz Warren J. | Director | SELL | $180.32 | 725 | $130,732 | 3,971 | -15.4% |
| 2024-05-16 23:09 | 2024-05-14 | Singer Maria Ruderman | Director | OPT+S | $179.29 | 1,689 | $302,827 | 3,168 | 0.0% |
| 2024-03-11 23:06 | 2024-03-08 | FILTON STEVE | Officer - Executive Vice President & CFO | OPT+S | $176.82 | 35,000 | $6,188,630 | 68,785 | 0.0% |
| 2024-03-06 00:24 | 2024-03-04 | Peterson Matthew Jay | Officer - Executive Vice President, UHS | OPT+S | $175.44 | 14,272 | $2,503,928 | 459 | 0.0% |
| 2024-03-05 00:11 | 2024-03-01 | SUSSMAN ELLIOT J MD MBA | Director | OPT+S | $170.99 | 3,492 | $597,104 | 3,951 | 0.0% |
| 2023-12-20 00:17 | 2023-12-01 | Chen-Langenmayr Nina | Director | SELL | $138.64 | 1,405 | $194,789 | 1,488 | -48.6% |
| 2023-12-20 00:17 | 2023-12-06 | Chen-Langenmayr Nina | Director | BUY | $136.73 | 250 | $34,183 | 1,738 | +16.8% |
| 2023-06-14 23:25 | 2023-06-13 | Nimetz Warren J. | Director | SELL | $140.97 | 800 | $112,776 | 2,944 | -21.4% |
| 2023-05-18 19:06 | 2023-05-17 | McDonnell Eileen C. | Director | SELL | $134.64 | 1,680 | $226,189 | 5,316 | -24.0% |
| 2023-05-13 00:18 | 2023-05-10 | McDonnell Eileen C. | Director | OPT+S | $141.53 | 3,107 | $439,744 | 5,508 | 0.0% |
| 2023-05-12 23:27 | 2023-05-11 | Nimetz Warren J. | Director | SELL | $139.01 | 500 | $69,507 | 2,256 | -18.1% |
| 2023-05-12 23:22 | 2023-05-11 | FILTON STEVE | Officer - Executive Vice President & CFO | SELL | $139.08 | 25,000 | $3,477,000 | 93,800 | -21.0% |
| 2023-05-12 23:07 | 2023-05-10 | Miller Marc D | Director, Officer - President and CEO | SELL | $142.65 | 44,110 | $6,292,115 | 0 | -100.0% |
| 2023-03-09 00:21 | 2023-03-07 | Gibbs Lawrence S. | Director | SELL | $122.31 | 793 | $96,992 | 2,230 | -26.2% |
| 2023-03-07 00:04 | 2023-03-03 | Gibbs Lawrence S. | Director | SELL | $128.29 | 1,568 | $201,159 | 3,023 | -34.2% |
| 2022-03-14 16:43 | 2022-03-11 | Gibbs Lawrence S. | Director | SELL | $153.00 | 1,307 | $199,971 | 1,869 | -41.2% |
| 2022-03-02 00:25 | 2022-02-28 | McDonnell Eileen C. | Director | OPT+S | $141.17 | 296 | $41,786 | 3,577 | 0.0% |
| 2022-03-02 00:06 | 2022-03-01 | Gibbs Lawrence S. | Director | OPT+S | $143.84 | 985 | $141,682 | 3,176 | 0.0% |
| 2021-07-28 21:55 | 2021-07-28 | Gibbs Lawrence S. | Director | SELL | $160.00 | 314 | $50,240 | 2,763 | -10.2% |
| 2021-05-11 17:30 | 2021-05-10 | SUSSMAN ELLIOT J MD MBA | Director | OPT+S | $157.88 | 2,553 | $403,068 | 0 | 0.0% |
| 2021-05-11 17:25 | 2021-05-07 | McDonnell Eileen C. | Director | SELL | $155.88 | 3,660 | $570,535 | 3,577 | -50.6% |
| 2021-04-30 18:37 | 2021-04-29 | Peterson Matthew Jay | Officer - Executive Vice President, UHS | OPT+S | $149.82 | 5,122 | $767,360 | 173 | 0.0% |
| 2021-04-29 20:20 | 2021-04-28 | McDonnell Eileen C. | Director | OPT+S | $148.43 | 2,483 | $368,552 | 7,237 | 0.0% |
| 2021-03-08 21:24 | 2021-03-05 | McDonnell Eileen C. | Director | OPT+S | $130.41 | 550 | $71,728 | 7,237 | 0.0% |
| 2020-03-12 17:53 | 2020-03-11 | Gibbs Lawrence S. | Director | OPT+S | $111.63 | 3,900 | $435,365 | 1,299 | 0.0% |
| 2019-12-13 18:46 | 2019-12-12 | Miller Marc D | Director, Officer - President | OPT+S | $144.51 | 8,013 | $1,157,994 | 141,209 | 0.0% |
| 2019-11-18 17:46 | 2019-11-15 | FILTON STEVE | Officer - Executive Vice President & CFO | SELL | $141.40 | 30,000 | $4,242,000 | 265,238 | -10.2% |
| 2019-07-31 23:34 | 2019-07-30 | Gibbs Lawrence S. | Director | SELL | $151.44 | 1,798 | $272,296 | 4,915 | -26.8% |
| 2019-07-30 20:02 | 2019-07-29 | Pember Marvin G. | Officer - Executive Vice President | OPT+S | $149.54 | 16,693 | $2,496,226 | 33,379 | 0.0% |
| 2019-07-30 19:52 | 2019-07-29 | McDonnell Eileen C. | Director | OPT+S | $147.96 | 6,455 | $955,082 | 7,237 | 0.0% |
| 2019-07-30 19:50 | 2019-07-29 | HOTZ ROBERT H | Director | OPT+S | $148.01 | 7,309 | $1,081,805 | 52,715 | 0.0% |
| 2017-03-09 21:05 | 2017-03-08 | FILTON STEVE | Officer - Senior Vice President & CFO | SELL | $123.80 | 10,000 | $1,237,950 | 257,492 | -3.7% |
| 2016-06-10 16:32 | 2016-06-09 | OSTEEN DEBRA K | Officer - Senior Vice President | OPT+S | $138.27 | 6,756 | $934,152 | 87,461 | 0.0% |
| 2016-06-06 19:37 | 2016-06-03 | Pember Marvin G. | Officer - Senior Vice President | OPT+S | $135.70 | 16,105 | $2,185,449 | 10,068 | 0.0% |
| 2016-06-02 22:54 | 2016-06-01 | OSTEEN DEBRA K | Officer - Senior Vice President | SELL | $135.81 | 18,749 | $2,546,302 | 88,440 | -17.5% |
| 2016-06-02 22:47 | 2016-06-02 | FILTON STEVE | Officer - Senior Vice President & CFO | OPT+S | $136.01 | 15,000 | $2,040,150 | 267,492 | 0.0% |
| 2016-05-11 20:14 | 2016-05-11 | HERRELL JOHN H | Director | OPT+S | $136.09 | 6,000 | $816,540 | 14,839 | 0.0% |
| 2016-05-05 23:23 | 2016-05-05 | PANTALEONI ANTHONY | Director | OPT+S | $133.51 | 6,995 | $933,902 | 0 | 0.0% |
| 2016-03-09 18:48 | 2016-03-08 | HOTZ ROBERT H | Director | OPT+S | $113.06 | 7,077 | $800,154 | 42,411 | 0.0% |
How to Interpret $UHS Trades
Not every insider transaction in UNIVERSAL HEALTH SERVICES INC is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $UHS shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for UHS
Insider activity data for UNIVERSAL HEALTH SERVICES INC is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $UHS, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.